Currently, the treatment for sarcoidosis includes first-line use of corticosteroids, followed by cytotoxic drugs as second-line treatment, and anti-tumor necrosis factor (TNF) biologics as third-line agents. The gene discussed is TNF; the disease is sarcoidosis.